About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Synthetic CBD as a Therapy for COVID-19

NCT04686539·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Howard Amital, MD, MHA
CONTACT
+972-3-5302638 Howard.Amital@sheba.health.gov.il

Lead

Sheba Medical Center

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

COVID 19 patients
18 Years and older

You may not be if

Respiratory failure requiring mechanical ventilation
Intensive care unit admission
Neutrophile con. \< 1000 cells/mm3
Lymphocyte con \< 500 cells/mm3
Liver enzymes 5 times higher then the norm
QT interval longer then 500 ms.
Pregnancy
Hemodialysis renal replacement therapy
Active or prior psychotic event

The record

StatusUnknown

PhasePhase 1

Taking part50

StartedJan 2021

UpdatedSep 28, 2021

Conditions

Where1

Sheba Medical Center, Tel Hashomer
Ramat Gan, Tel Aviv, Israel

Clareo Health | Synthetic CBD as a Therapy for COVID-19